U.S. Markets closed

Seer, Inc. (SEER)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
33.13-1.31 (-3.80%)
At close: 4:00PM EDT

Seer, Inc.

3800 Bridge Parkway
Suite 102
Redwood City, CA 94065
United States
650 453 0000
http://seer.bio

Sector(s)Healthcare
IndustryBiotechnology
Full Time Employees60

Key Executives

NameTitlePayExercisedYear Born
Dr. Omid C. Farokhzad Ph.D., M.D.Founder, CEO & Chair of the Board of Directors972.08kN/A1969
Mr. Omead OstadanPres, COO & Director745.74kN/A1972
Mr. David R. HornExec. VP & Chief Financial Officer554.29kN/A1968
Mr. Joe LawsChief Technology Officer and Co-FounderN/AN/AN/A
Ms. Elona Kogan J.D., Esq.Gen. Counsel & Sec.N/AN/A1969
Ms. Karen PossematoVP of Corp. Marketing & CommunicationsN/AN/AN/A
Mr. Shashanka MuppaneniVP of Corp. Devel.N/AN/AN/A
Ms. Marissa DixonVP & Chief People OfficerN/AN/AN/A
Dr. Serafim BatzoglouVP & Chief of ComputationN/AN/AN/A
Ms. Jennifer MaggioVP & Corp. ControllerN/AN/AN/A
Amounts are as of December 31, 2020 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Seer, Inc., a life sciences company, engages in developing and commercializing products for researchers to unlock biological information. The company develops Proteograph Product Suite, an integrated solution that comprises consumables, an automation instrumentation, and software that provides workflow to make proteomic profiling, and the analysis of the samples needed to characterize the nature of the proteome. It intends to sell its products for research purposes, which cover academic institutions, life sciences, and research laboratories, as well as biopharmaceutical and biotechnology companies for non-diagnostic and non-clinical purposes. Seer, Inc. has a collaboration agreement with Discovery Life Sciences, LLC. The company was formerly known as Seer Biosciences, Inc. and changed its name to Seer, Inc. in July 2018. Seer, Inc. was incorporated in 2017 and is headquartered in Redwood City, California.

Corporate Governance

Seer, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.